CClinicalTrials.gg
RecruitingNCT07401836Updated Mar 30, 2026

Standardized Sleep Bundle for Cardiac Surgery Patients

An interventional study of Standardized Sleep Protocol and Usual Post Operative Care in Sleep, sponsored by Horizon Health Network. Recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by Horizon Health Network · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the feasibility of using a standardized sleep bundle in adults undergoing cardiac surgery. The main questions it aims to answer are:

  1. Can eligible participants be recruited and retained in the study?
  2. Can participants follow the study procedures, including using sleep aids and completing daily assessments?
  3. Can sleep and other clinical data be reliably collected during the hospital stay? Researchers will compare participants who receive the sleep bundle to participants who receive usual postoperative care.

Participants will:

  • Use non-drug sleep aids, including a sleep mask, ear plugs, and a noise machine (sleep bundle group only).
  • Take sleep medications if needed, following a stepwise protocol (sleep bundle group only).
  • Complete daily sleep assessments using the Richards-Campbell Sleep Questionnaire (RCSQ).
  • Wear a Fitbit device at night to track sleep.
  • Follow usual postoperative care routines (control group)

The study will also collect and describe data on sleep duration, nighttime awakenings, subjective sleep quality, incidence of postoperative delirium, and hospital length of stay to inform the design of a future larger trial.

Read the detailed description

This study is a pilot randomized controlled trial designed to evaluate the feasibility and effects of a standardized sleep bundle on sleep quality in patients undergoing cardiac surgery. Adult patients scheduled for non-emergent cardiac surgery at the Saint John Regional Hospital (SJRH) will be screened for eligibility and enrolled after providing informed consent. Participants will be randomized to either usual postoperative care or the sleep bundle group.

The sleep bundle includes non-pharmacological interventions (sleep mask, ear plugs, nightly noise machine) and a stepwise pharmacological approach (melatonin, with trazodone or quetiapine added as needed). Sleep outcomes will be measured objectively using the Fitbit Inspire 3 device and subjectively using the Richards-Campbell Sleep Questionnaire (RCSQ). Feasibility will be assessed based on recruitment, retention, and adherence to the study protocol. Secondary outcomes include total sleep duration, nighttime awakenings, subjective sleep quality, incidence of postoperative delirium, and hospital length of stay.

All study procedures and daily assessments will be conducted by trained research personnel, with data analysis performed by a team member blinded to group allocation. This pilot study will inform the design of a future larger-scale trial.

02

Conditions studied

  • Sleep

Keywords

  • cardiovascular surgery
  • sleep
03

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients over 19 years old, undergoing non-emergent cardiac surgery with cardiopulmonary bypass at the Saint John Regional Hospital (SJRH).

Exclusion criteria

Exclusion Criteria:

  • Emergent surgery.
  • Severe renal or hepatic impairment (creatinine clearance (CrCl) \<30 mL/min, Chronic Kidney Disease (CKD) stage ≥4, cirrhosis, Alanine Transaminase (ALT) ≥ 3 × upper limit of normal (ULN)).
  • Sleep apnea.
  • Restless leg syndrome (RLS).
  • Insomnia with chronic use of pharmacological sleep aids prior to admission (trazodone, benzodiazepines, zopiclone, mirtazapine, quetiapine, tricyclic antidepressants [nortriptyline, amitriptyline, doxepin]).
  • Prior use of a monoamine oxidase inhibitor in the past 14 days.
  • Corrected QT Interval (QTc) > 500ms / history of prolonged QTc, Torsade de points or ventricular tachycardia.
  • History of dementia, alcohol, or opioid use disorder.
  • Documented or previous intolerance to melatonin, trazodone, or quetiapine. Unable to provide informed consent.

Run-in Period Exclusions:

After enrolment and before randomization, participants will be monitored for specific postoperative criteria. Those meeting any of the following criteria will be withdrawn prior to randomization.

  • Radial artery harvest required (unable to place Fitbit device on the wrist contralateral to the arterial monitoring line).
  • Prolonged intubation or sedation (> 48 hours) post-surgery.
  • Major intra- or early postoperative complications (stroke, transient ischemic attach (TIA), major bleeding, need for mechanical/circulatory support, reoperation, open chest, pulmonary embolism, acute renal failure requiring dialysis or other major surgical complications that would inhibit ability to participate).
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Sleep Bundle Group

    Participants in this group will receive a standardized sleep management protocol combining non-pharmacological interventions and stepwise pharmacotherapy.

    Other: Standardized Sleep Protocol

  • Active comparator
    Usual Post Operative Care

    Participants randomized to the control group will receive usual postoperative care.

    Other: Usual Post Operative Care

Interventions

  • OtherStandardized Sleep Protocol

    Non-Pharmacological Sleep Aids * All participants will be encouraged to wear a sleep mask and ear plugs nightly. In addition, a noise machine will be provided each night, the content and volume of which will be decided by the patient. * Stepwise Pharmacotherapy Approach Step 1: Melatonin \- Melatonin 6 mg orally at bedtime will be initiated for all participants in the sleep bundle group. Step 2: Adjunctive Therapy (Trazodone) * If the participants daily RCSQ score is below 63.4 or the participant reports inadequate sleep despite melatonin, trazodone will be scheduled orally at bedtime. * Trazodone will start at 25 mg and may be increased in 25 mg increments up to 100 mg orally at bedtime, based on participant response and tolerability. Step 3: Escalation for Delirium (Quetiapine) * If the participant has documented postoperative delirium, quetiapine 12.5 mg immediate release oral tablet will be scheduled at bedtime. * Dose may be increased in 12.5 mg increments up to 100 mg as cli

  • OtherUsual Post Operative Care

    Standard postoperative care without the structured sleep bundle. This includes routine clinical management of sleep without non-pharmacological interventions or protocolized pharmacological sleep aid. Any sleep medications administered will be at the discretion of the care team, without a standardized approach, reflecting standard practice.

05

What researchers measure

Primary outcomes

  1. Recruitment Rate

    Proportion of eligible patients who consent to participate in the study. Recruitment success is defined as greater than 50% of eligible patients enrolled. Reported as a percentage.

    Time frame: From first participant enrollment until last participant enrolled (approximately 8 weeks)

  2. Retention Rate

    Proportion of participants who complete the study. Retention success is defined as greater than 80% of participants completing the study. Reported as a percentage.

    Time frame: From enrollment until hospital discharge for each participant ( approximately 5 days)

  3. Protocol Adherence

    Proportion of daily study assessments completed by participants. Reported as a percentage of completed assessments out of total expected assessments.

    Time frame: Daily from Day 1 of enrollment through hospital discharge (approximately 5 days)

  4. Fitbit Adherence

    Number of nights the Fitbit is worn ( minimum 3 scheduled nights). Reported as count and percentage of participants meeting adherence criteria.

    Time frame: Each night from Day 1 of enrollment through hospital discharge (approximately 5 days)

  5. Time to Reach Target Sample Size

    Number of days required to enroll the target sample size of 20 participants. Reported in days.

    Time frame: From first participant enrolment to enrolment of the 20th participant ( approximately 8 weeks)

Secondary outcomes

  1. Total Sleep Duration

    Objective sleep duration will be measured using the Fitbit Inspire 3 device, worn on the wrist contralateral to the radial arterial line. The device records total sleep time nightly between 9:00 PM and 9:00 AM. Data will be summarized using daily means, standard deviations, medians, and interquartile ranges.

    Time frame: Nightly from postoperative day 1 through postoperative day 5 or hospital discharge, whichever occurs first.

  2. Nighttime Awakenings

    Objective nighttime awakenings will be measured using the Fitbit Inspire 3 device, recorded nightly between 9:00 PM and 9:00 AM. Daily counts of awakenings will be summarized using means, standard deviations, medians, and interquartile ranges.

    Time frame: Nightly from postoperative day 1 through postoperative day 5 or until hospital discharge, whichever occurs first

  3. Subjective Sleep Quality

    Subjective sleep quality will be assessed each morning using the Richards-Campbell Sleep Questionnaire (RCSQ), a validated 0-100 mm visual analog scale evaluating sleep depth, latency, awakenings, efficiency, and overall quality. Scores will be averaged across the five domains. Daily scores will be summarized using descriptive statistics.

    Time frame: Each morning from postoperative day 1 through postoperative day 5 or until hospital discharge, whichever occurs first

  4. Incidence of Postoperative Delirium

    Incidence of delirium will be recorded based on daily assessments documented by the care team in patient charts. Counts and percentages of participants experiencing delirium will be reported.

    Time frame: Daily from postoperative day 1 through postoperative day 5 or until hospital discharge, whichever occurs first.

  5. Hospital Length of Stay

    Length of stay will be recorded in days from the date of surgery to the date of discharge, as documented in the patient's medical record. Data will be summarized using descriptive statistics.

    Time frame: From day of surgery (postoperative day 0) through postoperative day 5 or until hospital discharge, whichever occurs first

06

Study locations

1 of 1 sites recruiting
  • Saint John Regional Hospital
    Saint John, New Brunswick E2L 4L2, Canada
    Recruiting
07

References and documents

Publications

  • Elliott R, Axelin A, Richards KC, Vahlberg T, Ritmala-Castren M. Sensitivity and specificity of proposed Richards-Campbell Sleep Questionnaire cut-off scores for good quality sleep during an ICU stay. J Clin Nurs. 2023 Jun;32(11-12):2700-2708. doi: 10.1111/jocn.16348. Epub 2022 May 15. PubMed 35570380 ↗
  • Haghayegh S, Khoshnevis S, Smolensky MH, Diller KR, Castriotta RJ. Accuracy of Wristband Fitbit Models in Assessing Sleep: Systematic Review and Meta-Analysis. J Med Internet Res. 2019 Nov 28;21(11):e16273. doi: 10.2196/16273. PubMed 31778122 ↗
  • Soh PQP, Wong WHT, Roy T, Tam WWS. Effectiveness of non-pharmacological interventions in improving sleep quality after cardiac surgery: A systematic review and meta-analysis. J Clin Nurs. 2024 Jun;33(6):2084-2098. doi: 10.1111/jocn.17115. Epub 2024 Mar 13. PubMed 38477050 ↗
  • Mahran GS, Leach MJ, Abbas MS, Abbas AM, Ghoneim AM. Effect of Eye Masks on Pain and Sleep Quality in Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial. Crit Care Nurse. 2020 Feb 1;40(1):27-35. doi: 10.4037/ccn2020709. PubMed 32006033 ↗
  • Liao WC, Huang CY, Huang TY, Hwang SL. A systematic review of sleep patterns and factors that disturb sleep after heart surgery. J Nurs Res. 2011 Dec;19(4):275-88. doi: 10.1097/JNR.0b013e318236cf68. PubMed 22089653 ↗
  • Simeone S, Pucciarelli G, Perrone M, Teresa R, Gargiulo G, Guillari A, Castellano G, Tommaso LD, Niola M, Iannelli G. Delirium in ICU patients following cardiac surgery: An observational study. J Clin Nurs. 2018 May;27(9-10):1994-2002. doi: 10.1111/jocn.14324. Epub 2018 Apr 25. PubMed 29493837 ↗
  • Zhang WY, Wu WL, Gu JJ, Sun Y, Ye XF, Qiu WJ, Su CQ, Zhang SQ, Ye WQ. Risk factors for postoperative delirium in patients after coronary artery bypass grafting: A prospective cohort study. J Crit Care. 2015 Jun;30(3):606-12. doi: 10.1016/j.jcrc.2015.02.003. Epub 2015 Feb 7. PubMed 25708120 ↗
  • Caruana N, McKinley S, Elliott R, Gholizadeh L. Sleep Quality During and After Cardiothoracic Intensive Care and Psychological Health During Recovery. J Cardiovasc Nurs. 2018 Jul/Aug;33(4):E40-E49. doi: 10.1097/JCN.0000000000000499. PubMed 29771744 ↗

Individual participant data

Plan to share: Undecided — The decision to share individual participant data has not yet been determined. Plans for data sharing will be considered once the feasibility and outcomes of the pilot study are evaluated.

08

Registry details

Key details

Study ID
NCT07401836
Lead sponsor
Horizon Health Network
Collaborators
New Brunswick Heart Centre
Responsible party
Caroline.Fitzpatrick (Principle Investigator, Horizon Health Network) — Principal investigator
First posted
Feb 11, 2026
Start date
Mar 2, 2026
Primary completion
May 29, 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Mar 30, 2026

Study contacts

Christopher W White, MD
Contact
Christopher.White@HorizonNB.ca
15066487782
Caroline E Fitzpatrick
principal investigator · Horizon Health Network

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion